Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Metsä Board's financial reporting and Annual General Meeting in 2019

Metsä Board Corporation Stock Exchange Release 15 August 2018 at 10.30 am EESTIn 2019, Metsä Board Corporation will publish the following financial reports: Financial Statements Bulletin for the year 2018           7 February 2019 Interim Report for January–March 2019                       26 April 2019 Half-Year Financial Report January–June 2019           1 August 2019 Interim Report for January–September 2019               31 October 2019 Annual Report 2018 including the financial statements, Board of Directors' report, the Corporate Governance statement and the salary and

Acando Norway acquires September BI – a company specialized in Analytics solutions for retail

From September 3, 2018, Acando Norway acquires 100 percent of the shares in September BI.September BI (www.septemberbi.no) is one of Norway's leading companies within Business Intelligence (BI) for Retail and Supply Chain Management. September BI has a proprietary solution, Retail Operational Intelligence, that controls and optimizes flows and provides customer insights. September BI’s has several significant customers including XXL, Intersport, G-Sport, Nille and Vita.  September BI employs approximately 20 senior consultants with deep expertise within relevant technologies and in

Electrolux invests in and partners with food waste startup Karma

Electrolux today announced it is investing in Sweden-based Karma, a leading startup that helps restaurants and supermarkets reduce food waste by selling unsold food to consumers. The investment is part of a wider USD 12 million round with other investors. Electrolux and Karma are also initiating a strategic partnership to explore common solutions in reducing food waste.The new partnership with Karma will explore new innovative solutions within the future of food and help to scale up the fight against food waste. The partnership will combine Electrolux expertise within appliances and food

Nordic Mining ASA (OAX: NOM) – Invitation to the presentation of the Q2 2018 results on Friday 17 August 2018 at 10:00 (CET)

We invite you to the presentation of the results for the second quarter 2018 and company updates in Nordic Mining’s office at Vika Atrium, Munkedamsveien 45 (Entrance A, 5th floor), N-0250 Oslo on Friday 17 August at 10:00 (CET). The quarterly report and presentation materials will be published at the Oslo Stock Exchange and on Nordic Mining's webpage (www.nordicmining.com) in advance of the presentation. The presentation and Q&A session will be held in English and transferred via webcast. You will have the opportunity to post questions online throughout the webcast session. The webcast

Addnode Group acquires software company Landborgen and strengthens its position as a leading provider of case management systems

Stockholm, August 15, 2018 - Addnode Group has acquired the software company Landborgen, which provides case management systems for the Swedish municipalities' permit and supervisory activities. The company is a leading supplier in its market segment and has net sales of approximately SEK 10 M.Landborgen has 20 years of experience in developing user-friendly and reliable case management solutions for licensing and supervision activities, including alcohol permits. The company's products AlkT and OL2 are used by more than 80 percent of Sweden's municipalities. In recent years, the company

Hi3G selects Ericsson to develop transport network for 5G in Denmark

· Ericsson will modernize Hi3G’s transport network with 5G-ready routers over the next three years · Expanded partnership will see Ericsson implement Router 6000 series to address Hi3G’s need for scalability, security and efficiency · Around 1.3 million Hi3G subscribers in Denmark will benefit from a robust, high capacity, 5G ready networkEricsson (NASDAQ: ERIC) has been selected by Hi3G, operating as 3 in Denmark, to modernize its transport network with 5G-ready routers over the next three years. The new IP Mobile Backhaul transformation project will see the implementation of

Parans Solar Lighting draws down a third tranche of convertibles of SEK 2 million

Parans Solar Lighting AB (publ) ("Parans") draws down a third tranche from European Select Growth Opportunities Fund (the "Investor") and issues free warrants to its shareholders.On 20 November 2017, Parans entered into an investment agreement with the Investor (the "Agreement"). On 8 March 2018, Parans and the Investor signed an amendment agreement relating to the Agreement (the "Amendment Agreement") providing, inter alia, the issuance of four tranches of SEK 2 million each, and Parans issued at this occasion a second tranche of SEK 2 million (see press release dated March 9, 2018). On

Vestas - Share buy-back programme of up to DKK 1,500m (approx. EUR 200m)

Vestas Wind Systems A/S, Aarhus, 15 August 2018                                                                                                         Company announcement No. 28/2018 Share buy-back programme of up to DKK 1,500m (approx. EUR 200m) The Board of Directors of Vestas Wind Systems A/S has decided to initiate a share buy-back programme of up to DKK 1,500m (approx. EUR 200m) to be executed during the period 15 August 2018 to 28 December 2018. The share buy-back programme is initiated pursuant to the authorisation granted to the Board of Directors by the annual general

Vestas - Interim financial report, second quarter 2018

Summary: Revenue on par with last year’s second quarter while earnings and free cash flow decreased. Solid order intake and combined order backlog at high level. Guidance for 2018 narrowed.  In the second quarter of 2018, Vestas generated revenue of EUR 2,260m – an increase of 2 percent compared to the year-earlier period. EBIT decreased by EUR 20m to EUR 259m. The EBIT margin was 11.5 percent compared to 12.6 percent in the second quarter of 2017 and free cash flow* amounted to EUR (173)m compared to EUR (158)m in the second quarter of 2017. The intake of firm and unconditional wind

Coloreel recruits from large international company

Coloreel continues to grow and now strengthens the company with recruitment from the international company ABB. New in the team is Benny Jonsson who is appointed as Vice President of Supply Chain from August."It feels amazing! Coloreel is an extremely exciting company with huge potential and it's extra fun to be apart of building the company at such an early stage, says Benny Jonsson", new Vice President of Supply Chain at Coloreel. Benny Jonsson is 44 years old and his latest employer was ABB in Västerås, where he worked as Production Manager. He has a broad background in production and

Bambuser AB (publ) publishes H1 2018

First 6 months – a restart for Bambuser January – June 2018 • Net sales amounted to 2,317 KSEK (3,468) • Total income amounted to 2,746 KSEK (5,279) • EBIT was -10,803 KSEK (-9,740) • Net income was -10,935 KSEK (-7,848) • Earnings per share of -0.72 SEK (-0.52) • Cash flow from operating activities was -10,850 KSEK (-5,642) • Cash at end of period was 16,273 KSEK (36,461)CEO Maryam Ghahremani comments: After assuming the position as Interim CEO of Bambuser March, 2018, with the mission to review the product and increase the short term revenues, I started working

New Australian patent approval for Episurf Medical

The Australian patent office IP Australia has announced that Episurf Medical (NASDAQ: EPIS B) has obtained another granted patent in Australia. The patent, entitled “Design method of a rig”, is within the area of individualised surgical instruments with a focus on the drill guide for the Episealer® Femoral Twin implant. "I’m happy to see how the Episealer® Femoral Twin technology is getting backed up by a strong patent coverage globally”, comments Pål Ryfors, CEO, Episurf Medical. For more  information, please contact: Pål Ryfors, CEO, Episurf Medical Tel:+46 (0) 709 62 36 69

Interim report January – June 2018

Click here  to watch the quarterly video with CEO Jonas Tellander and CFO Sofie Zettergren. For the full report see attached pdf.Highlights from Q2 2018 report · Subscriber base up 47% Y/Y to 621 200, on track to reach 800 000 in 2018 · Streaming sales up 43% Y/Y to 239 MSEK, on track to reach 1 000 MSEK in 2018 · International streaming sales now 47% of total, on track to surpass 50% in 2018 · Storytel launched in the UAE, Turkey and Italy · E-book reading device (Storytel Reader) launched at the end of June ·

WntResearch and Biovica in Foxy-5 biomarker collaboration

Biovica International AB (publ) have agreed to collaborate with WntResearch AB regarding a biomarker for Foxy-5 treatment. The objective of the research is to deliver a companion diagnostic, a biomarker, coupled with Foxy-5.Biovica and WntResearch acknowledge the possibility to utilize a blood sample to identify patients that will benefit from Foxy-5. The rationale for the collaboration are several studies demonstrating that thymidine kinase (TK) activity can be measured with high precision by Biovicas DiviTumÒassay and is strongly correlated to tumor aggressiveness. To investigate the

Journal of Clinical Oncology publishes that IMMray™ PanCan-d serum biomarker test detects early pancreatic cancer with 96% accuracy

LUND, SWEDEN ― Immunovia AB announced today that the prestigious Journal of Clinical Oncology (JCO) publishes the results of the major retrospective clinical validation study performed by Scandinavian and US researchers, showing that the IMMray™ PanCan-d serum biomarker microarray detects early pancreatic cancer with 96% accuracy.Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year survival of <10% because of diffuse symptoms leading to late-stage diagnosis. It is widely accepted that that survival could increase significantly if localized tumors could be detected

BAKKAFROST: Invitation to Presentation/Webcast of Q2 2018 results 21 August 2018 at 8:00 am (CET)

Q2 2018 PRESENTATION A presentation of Bakkafrost’s interim report Q2 2018 will be held at 8:00 am (CET) on 21 August 2018 at Hotel Continental, Stortingsgaten 24/26, Oslo, Norway. WEBCAST The presentation will be transmitted live on Bakkafrost's website www.bakkafrost.com. Bakkafrost´s interim report Q2 2018 and presentation will be released prior to market opening on 21 August 2018 at 6:00 am (CET). Contacts: Regin Jacobsen, CEO of P/F Bakkafrost: +298 235001 (mobile) Gunnar Nielsen, CFO of P/F Bakkafrost: +298 235060 (mobile) This information is subject of the

Interim report – Second quarter and first half-year of 2018

Attached please find the full interim report as PDF file.________________________________________________________________________________ Announcement no. 1115 August 2018 Today, the Board of Directors approved the interim report for the second quarter and first half-year of 2018. The report contains the following highlights: ResultsAdjusted Result* for Q2 2018: USD 4 million (Q2 2017: USD -3 million)• Dry Operator: USD 8 million• Dry Owner: USD 3 million• Tankers: USD -8 million (USD 3 million)EBIT Q2 2018: USD 8 million (USD -3 million) * ”Profit/loss for the

Study of depression and efficacy of treatment published with promising results and in line with the National Board of Health and Welfare guidelines

The study has focused on both being able to detect depression in patients but also to look at the effect of treatment in the form of medication with Citalopram. The study shows that SensoDetect BERA can discern with a high statistical significance of patients with depression and already after about 1 week discern the effect of treatment which is unique and completely in line with the National Board of Health and Welfare stated improvement goals.The study is an important part of the development that SensoDetect works with for both tests for initial assessment of mental ill-health and for the

Double Bond Pharmaceutical manufactures first GMP batch of SI053

Double Bond Pharmaceuticals contract manufacturer of SI053 reports that they have successfully manufactured the first GMP batch. The batch is to be used among other things for the stability study for SI053. “There is a lot of work behind this batch and we are very pleased to be able to start the stability study according to plan” says Charlotte Karlsson, Quality Assurance Manager and coordinator of the manufacturing projects. “Getting a material for future clinical trials is an important milestone in the drug development process” commented Igor Lokot, CEO of Double Bond Pharmaceutical.

AstraZeneca prices a $3bn bond issue

15 August 2018 07:00 BST AstraZeneca prices a $3bn bond issue AstraZeneca PLC announces that, on 14 August 2018, it priced a four tranche global bond offering totalling $3bn. The offering is expected to close on 17 August 2018, subject to customary closing conditions. AstraZeneca expects to use the net proceeds of the issue for general corporate purposes, which may include the refinancing of existing indebtedness. The transaction, which is a global offering registered with the US Securities and Exchange Commission (SEC), consists of the following four tranches: · $0.85bn of fixed

Invitation to presentation of AcadeMedia's full year result for July - June 2017/18

AcadeMedia's full year result for July - June 2017/18 will be published at 08:00 CET on August 29. A web-cast telephone conference will be held at 09:30 CEST the same day, where CEO Marcus Strömberg and CFO Eola Änggård Runsten will present the report. The presentation will be held in English and can be followed on the web or over the phone. It will be followed by a Q&A session. To participate in the conference call, and thereby be able to ask questions, call one of the following numbers ten minutes before the start of the call:UK: +442030089806SE: +46856642662US: +18557532235

PROGRESS IN FOCUS AREA MOBILE

INTERIM REPORT FOR THE PERIOD JANUARY TO JUNE 2018SECOND QUARTER  · Net sales for the remaining operation totaled SEK 18.7 (20.1) million. · The operating profit/loss for the remaining operation for the quarter totaled SEK -3.3 (0.5) million. · The profit/loss for the period for the remaining operation totaled SEK -4.1 (0.2) million. · Earnings per share for the remaining operation totaled SEK -0.01 (0.00). · Earnings per share for the total operation totaled SEK -0.01 (0.00). · Cash flow from total operating activities totaled SEK -8.6 (-1.3) million.

Stora Enso invests in building a Competence Centre and diversifying the raw material base for biocomposites

STORA ENSO OYJ INVESTOR NEWS 15 August 2018 at 9.00 EESTIn order to meet increasing customer demand, Stora Enso will broaden its biocomposites raw material base at the Hylte Mill, Sweden to provide more choice in technical properties and selection of fibres. The investment covers a new Biocomposites Competence Centre and the installation of new machinery for the milling of large fibres for the DuraSense™ by Stora Enso biocomposite material. “As we see an increasing demand for the innovative DuraSense™ biocomposite, the diversification of the raw material base and the new Biocomposites

There are no items matching the current filter
There are no more items matching the current filter
Back to top